FOLD News Alert Amicus Therapeutics (FOLD) 8.36 02/13/2015 2

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2015 at 10:51 PM

Amicus Therapeutics (FOLD) 8.36 $FOLD

4 Biotech Stocks Under $10 Triggering Breakouts: Amarin, Exelixis and More
at The Street - Tue Feb 10, 1:01PM CST
Keep these under-$10 biotech stocks on your breakout trading radar.
AMRN: 1.18 (unch), FOLD: 8.36 (-0.11), MEIP: 5.00 (-0.04), EXEL: 2.48 (+0.20)

Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015
GlobeNewswire - Tue Feb 10, 6:25AM CST
Optimized for Efficient Targeting to Multiple Key Muscle Tissues of Disease
FOLD: 8.36 (-0.11)

Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015
GlobeNewswire - Tue Feb 10, 6:25AM CST
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced positive data on pre-specified patient reported outcomes from both of its Phase 3 studies of the oral small molecule pharmacological chaperone migalastat HCl ("migalastat"

for Fabry disease at WORLDSymposium(TM) 2015 in Orlando, Florida.
FOLD: 8.36 (-0.11)

Amicus Therapeutics to Present at Leerink Global Healthcare Conference
GlobeNewswire - Wed Feb 04, 3:06PM CST
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will present a corporate overview at the Leerink Global Healthcare Conference in New York, NY on Wednesday, February 11, 2015 at 3:05 p.m. ET.
FOLD: 8.36 (-0.11)

Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics
PR Newswire - Wed Feb 04, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Celgene Corporation (NASDAQ: CELG), CytRx Corporation (NASDAQ: CYTR), Amicus Therapeutics Inc. (NASDAQ: FOLD), and United Therapeutics Corporation (NASDAQ: UTHR). Free research report on ARIAD Pharma can be accessed at http://get.Investor-Edge.com/pdf/?c=ARIAD%20P...amp;s=ARIA. On Tuesday, February 03, 2015, the NASDAQ Composite ended at 4,727.74, up 1.09%, the Dow Jones Industrial Average advanced 1.76%, to finish the day at 17,666.40, and the S&P 500 closed at 2,050.03, up 1.44%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 811.48, up 0.65%, with the index also advancing 4.16% in the previous three months. Register for your complimentary reports at the links given below.
UTHR: 151.11 (+3.59), CYTR: 2.96 (+0.23), ARIA: 7.35 (+0.45), FOLD: 8.36 (-0.11), CELG: 115.88 (+0.16), CELGZ: 3.17 (-0.04)

Amicus Therapeutics Shares Up 20.7% Since SmarTrend's Buy Recommendation (FOLD)
Comtex SmarTrend(R) - Thu Jan 29, 5:09PM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 20.72% as of today's recent price of $8.04.
FOLD: 8.36 (-0.11)

Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium
GlobeNewswire - Mon Jan 26, 6:30AM CST
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that 2 oral presentations and 6 posters highlighting its development programs for lysosomal storage diseases will be included at the 11 Annual Lysosomal Disease Network WORLD Symposium (LDN WORLD), to be held February 9-13, 2015 in Orlando, FL.
FOLD: 8.36 (-0.11)

Uptrend Call Working As Amicus Therapeutics Stock Rises 18.3% (FOLD)
Comtex SmarTrend(R) - Thu Jan 22, 11:19AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 18.32% as of today's recent price of $7.88.
FOLD: 8.36 (-0.11)

Netflix's Cult Surprise - Cramer's Mad Money (1/21/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Jan 22, 6:25AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, January 21, 2015 Wednesday's rally will likely be ascribed by many to the ECB's initiative of kickstarting Europe's economy on Thursday. Others will point to...
AMZN: 381.83 (+4.66), TSLA: 203.77 (+0.89), GPRO: 45.27 (-0.02), GOLD: 78.29 (-0.31), UNH: 109.44 (-0.40), TGTX: 13.13 (-0.19), LEA: 108.70 (-0.73), TWX: 83.87 (+0.56), NFLX: 466.10 (+9.37), PM: 82.87 (-0.82), ETP: 60.17 (+0.96), NTRS: 70.08 (-0.51), EBAY: 56.47 (+1.73), IBM: 160.40 (+1.88), USB: 45.07 (-0.05), TWC: 149.74 (+2.21), FOLD: 8.36 (-0.11)

Jim Cramer's Top Stock Picks: NFLX FOLD TGTX
at The Street - Thu Jan 22, 5:00AM CST
Cramer said Netflix can thank binge buying for its share surge while Amicus Therapeutics and TG Therapeutics are biotechs with plenty of potential.
NFLX: 466.10 (+9.37), TGTX: 13.13 (-0.19), FOLD: 8.36 (-0.11)

Jim Cramer's 'Mad Money' Recap: Netflix Binge Buying Powered Today's Rally
at The Street - Wed Jan 21, 7:21PM CST
Does a single stock have the power to move the markets? Apparently Netflix does, Cramer says.
72.91 (-0.81), TSLA: 203.77 (+0.89), ODFL: 76.25 (+0.96), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), GBX: 57.22 (-0.59), UNH: 109.44 (-0.40), KMB: 111.00 (+0.82), SDRL: 12.32 (-0.70), CVRR: 20.20 (+0.58), TWX: 83.87 (+0.56), LUV: 43.30 (-0.20), JNJ: 99.62 (+1.18), RICE: 19.13 (-0.22), IBM: 160.40 (+1.88), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), CY: 14.76 (+0.01), AMZN: 381.83 (+4.66), GPRO: 45.27 (-0.02), SWKS: 81.85 (-0.57), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSLT: 9.19 (+0.13), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), IDTI: 20.56 (-0.38), PCLN: 1,103.37 (+11.42), NFLX: 466.10 (+9.37), AGEN: 5.03 (-0.01), UA: 73.76 (-0.19), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), SNDK: 82.81 (+0.51), EPD: 34.44 (+0.19), FOLD: 8.36 (-0.11), BABA: 89.05 (+1.95)

Amicus Therapeutics Has Driven Value Through The Clinic
Stephen Simpson, CFA - at Seeking Alpha - Wed Jan 21, 2:03PM CST

SHPG: 239.82 (+6.11), SNY: 49.42 (+0.82), FOLD: 8.36 (-0.11)

23.1% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Thu Jan 15, 9:53AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 23.12% as of today's recent price of $8.20.
FOLD: 8.36 (-0.11)

Operating chief at Amicus adds a title
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 6:30AM CST

FOLD: 8.36 (-0.11)

Amicus provides 2015 outlook
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:31PM CST

FOLD: 8.36 (-0.11)

Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
MAA Submission for Migalastat Monotherapy for Fabry Disease on Track for Mid-2015
FOLD: 8.36 (-0.11)

Amicus Therapeutics (FOLD) Weak On High Volume
at The Street - Fri Jan 09, 9:03AM CST
Trade-Ideas LLC identified Amicus Therapeutics (FOLD) as a weak on high relative volume candidate
FOLD: 8.36 (-0.11)

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
at The Street - Thu Jan 08, 12:09PM CST
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
OREX: 5.55 (+0.10), BIIB: 391.66 (-0.45), VRTX: 113.66 (+4.03), ESRX: 84.90 (+0.40), ACAD: 34.21 (+0.37), PCYC: 163.28 (+0.23), GILD: 101.90 (+1.10), NPSP: 45.88 (+0.03), SNY: 49.42 (+0.82), FOLD: 8.36 (-0.11), CELG: 115.88 (+0.16)

Migalstat HCL has positive impact on cardiac endpoint in Fabry study
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 10:31AM CST

FOLD: 8.36 (-0.11)

41.4% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Thu Jan 08, 9:09AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 41.44% as of today's recent price of $9.42.
FOLD: 8.36 (-0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Agents Race: 10M Downloads Spark Competitive Fire

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

King City Gardens Debuts Third Dispensary in Cincinnati

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

AMTD IDEA Group: Expanding Its Global Reach

AMTD IDEA's Expansive Global Footprint While the rest of the market whirls, AMTD IDEA Group (NYSE: AMTD) is steadying itself with a comprehensive expansion that, quite frankly, demands a second look. Between weaving global media threads and dipping their toes into every alluring venture space, they've formed a tapestry not many could replicate. With facilities stretching...

Shadeform Debuts Flex VMs, Revolutionizing GPU Utilization

GPU Utilization Gets a New Spin with Flex VMs Folks, listen up: Shadeform just fired up something slick with its new Flex VMs. And, let me tell you, in today's market where GPU capacity is vanishing faster than free hotcakes on a Sunday morning, this might well be a game changer. Shadeform’s the name to remember, teaming up data center veterans with peeps who need to...

Meitav Tops 2025 Service Index with Stellar Growth

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Short Term Shop Hits $500M in Airbnb Sales Milestone

Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...

Bryan Cranston Stars in Live Streaming 'A Christmas Carol'

Cranston Climbs Into Scrooge's Shoes for a Cause If you think you've got the holiday season all figured out, add this curveball: Bryan Cranston as Ebenezer Scrooge, jawing through "A Christmas Carol" as part of a unique, one-night-only staged reading. And it's not just another star-studded ploy for attention. It's about rallying around a cause bigger than holiday cheer,...

Mastering Power Efficiency with Phase Converters

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Prosecco DOC Chef Residency Debriefs on Inaugural Year

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

OSV Talks Launches New Season on Ministry Growth

A Fresh Wave of Ideas for Catholic Ministry Some topics never go out of style, and it looks like the crew at OSV is banking on that with their latest salvo of OSV Talks. With themes ranging from peacemaking to AI, they're tossing it all against the spiritual wall, hoping it sticks. The comeback of their video series has that classic 'get your act together' vibe we all...